Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfreundschuh

Showing results (161-170 of 260) with videos related to

Pageof 26
Sort By:
Blood|April 1, 1996
Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical modelC Renner, S Bauer, U Sahin, et al.
Deutsche Medizinische Wochenschrift (1946)|June 9, 1995
[Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas]H Daus, L Trümper, B Bürger, et al.
International Journal of Cancer|October 10, 1998
Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategiesU Sahin, O Türeci, Y T Chen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 6, 2000
Definition of tumor-associated antigens in hepatocellular carcinomaF Stenner-Liewen, G Luo, U Sahin, et al.
Cancer Research|January 1, 1990
Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's diseaseA Engert, F Burrows, W Jung, et al.
International Journal of Cancer|May 15, 1990
Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T-cell leukemia and infectious mononucleosisM Pfreundschuh, C Pohl, C Berenbeck, et al.
Clinical and Experimental Rheumatology|September 24, 2009
Association of rheumatoid arthritis with Mdm2 SNP309 and genetic evidence for an allele-specific interaction between MDM2 and p53 P72R variants: a case control studyG Assmann, J Voswinkel, M Mueller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: a German multicenter phase II studyM J Rummel, G Käfer, M Pfreundschuh, et al.
Leukemia|July 10, 2014
Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimensK Hohloch, S Zeynalova, G Held, et al.
International Journal of Cancer|May 28, 1993
CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphomaC Pohl, C Renner, M Schwonzen, et al.
Pageof 26

Showing results (161-170 of 260) with videos related to

Sort By:
Pageof 26
Blood|April 1, 1996
Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical modelC Renner, S Bauer, U Sahin, et al.
Deutsche Medizinische Wochenschrift (1946)|June 9, 1995
[Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas]H Daus, L Trümper, B Bürger, et al.
International Journal of Cancer|October 10, 1998
Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategiesU Sahin, O Türeci, Y T Chen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 6, 2000
Definition of tumor-associated antigens in hepatocellular carcinomaF Stenner-Liewen, G Luo, U Sahin, et al.
Cancer Research|January 1, 1990
Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's diseaseA Engert, F Burrows, W Jung, et al.
International Journal of Cancer|May 15, 1990
Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T-cell leukemia and infectious mononucleosisM Pfreundschuh, C Pohl, C Berenbeck, et al.
Clinical and Experimental Rheumatology|September 24, 2009
Association of rheumatoid arthritis with Mdm2 SNP309 and genetic evidence for an allele-specific interaction between MDM2 and p53 P72R variants: a case control studyG Assmann, J Voswinkel, M Mueller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: a German multicenter phase II studyM J Rummel, G Käfer, M Pfreundschuh, et al.
Leukemia|July 10, 2014
Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimensK Hohloch, S Zeynalova, G Held, et al.
International Journal of Cancer|May 28, 1993
CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphomaC Pohl, C Renner, M Schwonzen, et al.
Pageof 26